• Publications
  • Influence
Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients.
Increased plasma catecholamine levels induced an a 2 and b 2 -adrenoceptor downregulation and autonomic nervous system dysfunction and adrenoceptor alterations in the pathophysiology of CH HD patients.
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study
There is a risk of developing diabetes mellitus or experiencing changes in glucose metabolism in statin-treated patients, and the possible determining factors are the drug characteristics, patient characteristics and the pre-diabetic state.
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Blood pressure control and proteinuria reduction delay progression of CKD and reduce cardiovascular risk, and control of both factors should be the treatment objective.
Anaemia in CKD 1-5